Which stocks can go from zero to one hundred overnight? Wall Street pros point to biotechs.
With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced additional results of the phase 2 clinical trial with obeticholic acid (OCA), a potent farnesoid X receptor agonist …
A first glance at this hedge fund’s strategic Q2 moves in biotech sector.
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare Provider (DHCP) letter issued on September 12, 2017, …
Intercept Sank 40% in September following Dear Doctor and FDA warning letters; Ritu Baral weighs in.
Shares of drug maker Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are in a freefall today. Why?
Dear doctor: My shares just fell 15%.